CDCA
Total Payments
$112,246
Transactions
17
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $6,050 | 3 | 1 |
| 2018 | $106,196 | 14 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $104,108 | 11 | 92.7% |
| Travel and Lodging | $8,037 | 3 | 7.2% |
| Food and Beverage | $102.20 | 3 | 0.1% |
Ad
Manufacturing Companies
- Leadiant Biosciences, Inc. $112,246
Product Information
- Type Drug
- Total Payments $112,246
- Total Doctors 3
- Transactions 17
About CDCA
CDCA is a drug associated with $112,246 in payments to 3 healthcare providers, recorded across 17 transactions in the CMS Open Payments database. The primary manufacturer is Leadiant Biosciences, Inc..
Payment data is available from 2018 to 2020. In 2020, $6,050 was paid across 3 transactions to 1 doctors.
The most common payment nature for CDCA is "Consulting Fee" ($104,108, 92.7% of total).